Jan Dörrie

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 27

Top Topics

Acute Myeloid Leukemia

Monoclonal Antibody

Immune Response

Top Venues

International journal of molecular sciences

Journal for immunotherapy of cancer

The Journal of cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Lischer, Martin Eberhardt, Cindy Flamann, Johannes Berges, Esther Güse, Anja Wessely, Adrian Weich, Jimmy Retzlaff, Jan Dörrie, Niels Schaft, Manuel Wiesinger, Johannes März, Beatrice Schuler-Thurner, Harald Knorr, Shailendra Gupta, Krishna Pal Singh, Gerold Schuler, Markus Vincent Heppt, Elias Andreas Thomas Koch, Nadine D van Kleef, Julian J Freen-van Heeren, Annelies W Turksma, Olaf Wolkenhauer, Bettina Hohberger, Carola Berking, Heiko Bruns, Julio Vera
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Christopher Lischer, Martin Eberhardt, Cindy Flamann, Johannes Berges, Esther Güse, Anja Wessely, Adrian Weich, Jimmy Retzlaff, Jan Dörrie, Niels Schaft, Manuel Wiesinger, Johannes März, Beatrice Schuler-Thurner, Harald Knorr, Shailendra Gupta, Krishna Pal Singh, Gerold Schuler, Markus Vincent Heppt, Elias Andreas Thomas Koch, Nadine D van Kleef, Julian J Freen-van Heeren, Annelies W Turksma, Olaf Wolkenhauer, Bettina Hohberger, Carola Berking, Heiko Bruns, Julio Vera
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie
Tumor Antigens beyond the Human Exome. International journal of molecular sciences 25 (9) (2024)
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie
Tumor Antigens beyond the Human Exome. International journal of molecular sciences 25 (9) (2024)
Christopher Lischer, Martin Eberhardt, Cindy Flamann, Johannes Berges, Esther Güse, Anja Wessely, Adrian Weich, Jimmy Retzlaff, Jan Dörrie, Niels Schaft, Manuel Wiesinger, Johannes März, Beatrice Schuler-Thurner, Harald Knorr, Shailendra Gupta, Krishna Pal Singh, Gerold Schuler, Markus Vincent Heppt, Elias Andreas Thomas Koch, Nadine D van Kleef, Julian J Freen-van Heeren, Annelies W Turksma, Olaf Wolkenhauer, Bettina Hohberger, Carola Berking, Heiko Bruns, Julio Vera
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Amanda Katharina Binder, Franziska Bremm, Jan Dörrie, Niels Schaft
Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells-Function and Therapeutic Potential. International journal of molecular sciences 25 (13) (2024)
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie
Tumor Antigens beyond the Human Exome. International journal of molecular sciences 25 (9) (2024)
Amanda Katharina Binder, Franziska Bremm, Jan Dörrie, Niels Schaft
Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells-Function and Therapeutic Potential. International journal of molecular sciences 25 (13) (2024)
Christopher Lischer, Martin Eberhardt, Cindy Flamann, Johannes Berges, Esther Güse, Anja Wessely, Adrian Weich, Jimmy Retzlaff, Jan Dörrie, Niels Schaft, Manuel Wiesinger, Johannes März, Beatrice Schuler-Thurner, Harald Knorr, Shailendra Gupta, Krishna Pal Singh, Gerold Schuler, Markus Vincent Heppt, Elias Andreas Thomas Koch, Nadine D van Kleef, Julian J Freen-van Heeren, Annelies W Turksma, Olaf Wolkenhauer, Bettina Hohberger, Carola Berking, Heiko Bruns, Julio Vera
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Dennis Christoph Harrer, Jan Dörrie, Niels Schaft
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. International journal of molecular sciences 24 (3) (2023)
Dennis Christoph Harrer, Jan Dörrie, Niels Schaft
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. International journal of molecular sciences 24 (3) (2023)
Dennis Christoph Harrer, Jan Dörrie, Niels Schaft
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. International journal of molecular sciences 24 (3) (2023)
Lukas Heger, Lukas Hatscher, Chunguang Liang, Christian H K Lehmann, Lukas Amon, Jennifer J Lühr, Tomasz Kaszubowski, Rayk Nzirorera, Niels Schaft, Jan Dörrie, Pascal Irrgang, Matthias Tenbusch, Meik Kunz, Eileen Socher, Stella E Autenrieth, Ariawan Purbojo, Horia Sirbu, Arndt Hartmann, Christoph Alexiou, Robert Anton Cesnjevar, Diana Dudziak
XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors. Proceedings of the National Academy of Sciences of the United States of America 120 (33) (2023)
Dennis Christoph Harrer, Charlotte Schenkel, Carola Berking, Wolfgang Herr, Hinrich Abken, Jan Dörrie, Niels Schaft
Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells. Cancers 14 (20) (2022)
Astrid Strack, Andrea Deinzer, Christian Thirion, Silke Schrödel, Jan Dörrie, Tatjana Sauerer, Alexander Steinkasserer, Ilka Knippertz
Breaking Entry-and Species Barriers: LentiBOOST ® Plus Polybrene Enhances Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5. Viruses 14 (1) (2022)
Amke C Beenen, Tatjana Sauerer, Niels Schaft, Jan Dörrie
Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases. International journal of molecular sciences 23 (15) (2022)
Laura Gehrcken, Tatjana Sauerer, Niels Schaft, Jan Dörrie
T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options. International journal of molecular sciences 22 (16) (2021)
Stefanie Hoyer, Valentina Eberlein, Gerold Schuler, Carola Berking, Lucie Heinzerling, Niels Schaft, Jan Dörrie
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation. International journal of molecular sciences 22 (21) (2021)
Naomi C Bosch, Lena-Marie Martin, Caroline J Voskens, Carola Berking, Barbara Seliger, Gerold Schuler, Niels Schaft, Jan Dörrie
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells. International journal of molecular sciences 22 (19) (2021)
Naomi C Bosch, Reinhard E Voll, Caroline J Voskens, Stefanie Gross, Barbara Seliger, Gerold Schuler, Niels Schaft, Jan Dörrie
NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells. Therapeutic advances in medical oncology 11 (2019)
Christopher Lischer, Martin Eberhardt, Tanushree Jaitly, Cornelia Schinzel, Niels Schaft, Jan Dörrie, Gerold Schuler, Julio Vera
Curatopes Melanoma: A Database of Predicted T-cell Epitopes from Overly Expressed Proteins in Metastatic Cutaneous Melanoma. Cancer research 79 (20) (2019)
Dennis C Harrer, Jan Dörrie, Niels Schaft
CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges. International journal of molecular sciences 20 (23) (2019)
Manuel Wiesinger, Johannes März, Mirko Kummer, Gerold Schuler, Jan Dörrie, Beatrice Schuler-Thurner, Niels Schaft
Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. Cancers 11 (8) (2019)
Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy. International journal of molecular sciences 19 (1) (2018)
Jan Dörrie
Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy. EMBO molecular medicine 9 (2) (2018)
Aykut Turan, Linda Grosche, Adalbert Krawczyk, Petra Mühl-Zürbes, Christina Drassner, Alexandra Düthorn, Mirko Kummer, Mike Hasenberg, Sylvia Voortmann, Holger Jastrow, Jan Dörrie, Niels Schaft, Max E Kraner, Katinka Döhner, Beate Sodeik, Alexander Steinkasserer, Christiane Silke Heilingloh
Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1. The Journal of cell biology 218 (2) (2018)
Ilka Knippertz, Andrea Deinzer, Jan Dörrie, Niels Schaft, Dirk M Nettelbeck, Alexander Steinkasserer
Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation. Journal of immunology research 2016 (2016)